Preliminary results from KEYNOTE-055: Pembrolizumab after platinum and cetuximab failure in head and neck squamous cell carcinoma (HNSCC).

被引：0
|
作者：
Bauml, Joshua
Seiwert, Tanguy Y.
Pfister, David G.
Worden, Francis P.
Liu, Stephen V.
Gilbert, Jill
Saba, Nabil F.
Weiss, Jared
Wirth, Lori J.
Sukari, Ammar
Kang, Hyunseok
Gibson, Michael K.
Massarelli, Erminia
Powell, Steven Francis
Meister, Amy
Shu, Xinxin
Cheng, Jonathan D.
Haddad, Robert I.
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[5] Georgetown Univ Hosp, Washington, DC 20007 USA
[6] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[7] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[8] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[9] Massachusetts Gen Hosp, Boston, MA 02114 USA
[10] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[11] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[12] Univ Hosp Case Med Ctr, Cleveland, OH USA
[13] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[14] Sanford Hlth, Sioux Falls, SD USA
[15] Merck & Co Inc, Kenilworth, NJ USA
[16] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6011
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012
    Tahara, Makoto
    Muro, Kei
    Hasegawa, Yasuhisa
    Chung, Hyun Cheol
    Lin, Chia-Chi
    Keam, Bhumsuk
    Takahashi, Kenichi
    Cheng, Jonathan D.
    Bang, Yung-Jue
    CANCER SCIENCE, 2018, 109 (03): : 771 - 776
  • [42] Survival in patients with relapsed/metastatic head and neck squamous cell carcinoma (HNSCC) treated with pembrolizumab or cetuximab-based therapy: A realworlddata study with the TriNetX platform
    Ugidos De La Varga, L.
    Ruiz del Arbol, N.
    Hernandez-Ibarburu, G.
    Delia, E.
    Peinado, P.
    Torres Velasco, M.
    Alvarez Gallego, R.
    Sanchez-Miguel, C. G. Munoz
    Garcia Morillo, M.
    Toledano, C.
    Cubillo, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S587 - S587
  • [43] A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC).
    Dunn, Lara
    Sherman, Eric Jeffrey
    Ho, Alan Loh
    Ganly, Ian
    Riaz, Nadeem
    Morris, Luc
    Hung, Kin Wai
    Kriplani, Anuja
    Cracchiolo, Jennifer R.
    Cohen, Marc
    Boyle, Jay
    Patel, Snehal G.
    Haque, Sofia
    Katabi, Nora
    Ghossein, Ronald A.
    McBride, Sean Matthew
    Michel, Loren S.
    Wong, Richard J.
    Lee, Nancy Y.
    Pfister, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040) : Subgroup analysis by pattern of disease recurrence
    Harrington, K. J.
    Cohen, E. E. W.
    Soulieres, D.
    Dinis, J.
    Licitra, L.
    Ahn, M. -j.
    Soria, A.
    Machiels, J. -p.
    Mach, N.
    Mehra, R.
    Burtness, B.
    Swaby, R. F.
    Lin, J.
    Ge, J.
    Lerman, N.
    Le Tourneau, C.
    ORAL ONCOLOGY, 2023, 147
  • [45] Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma
    Morecroft, Renee
    Phillipps, Jordan
    Zhou, Alice
    Butt, Omar
    Khaddour, Karam
    Johanns, Tanner
    Ansstas, George
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [46] Novel Predictive Biomarkers in the Head and Neck Squamous Cell Carcinoma (HNSCC)
    Miniuk, Magdalena
    Reszec-Gielazyn, Joanna
    Bortnik, Piotr
    Borsukiewicz, Agata
    Mroczek, Aleksandra
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [47] LncRNAs as prognostic biomarkers in head and neck squamous cell carcinoma (HNSCC)
    Chaudhary, Ritu
    Wang, Xuefeng
    Cao, Biwei
    Gimbrone, Nicholas T.
    Slebos, Robbert J. C.
    Chung, Christine H.
    CANCER RESEARCH, 2019, 79 (13)
  • [48] Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
    F Lemaire
    R Millon
    J Young
    A Cromer
    C Wasylyk
    I Schultz
    D Muller
    P Marchal
    C Zhao
    D Melle
    L Bracco
    J Abecassis
    B Wasylyk
    British Journal of Cancer, 2003, 89 : 1940 - 1949
  • [49] Tumour stem cells in head and neck squamous cell carcinoma (HNSCC)
    Goldie, S. J.
    Watt, F. M.
    Price, R.
    ORAL ONCOLOGY, 2009, : 72 - 72
  • [50] TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience
    Loerincz, B. B.
    Knecht, R.
    B-ENT, 2015, 11 : 33 - 36
12345